Cyclohexyldiamines as selective alpha 1a/1d adrenoreceptor antagonists for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms

Details for Australian Patent Application No. 2005302514 (hide)

Owner Janssen Pharmaceutica, N.V.

Inventors Liu, Jessica J.; Connolly, Peter J.; Pulito, Virginia L.; Middleton, Steven A.; Li, Shengjian; Chiu, George

Agent Shelston IP

Pub. Number AU-A-2005302514

PCT Pub. Number WO2006/050048

Priority 60/623,609 29.10.04 US

Filing date 28 October 2005

Wipo publication date 11 May 2006

International Classifications

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

C07D 295/116 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

Event Publications

24 May 2007 PCT application entered the National Phase

  PCT publication WO2006/050048 Priority application(s): WO2006/050048

22 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005302516-Chemically defined media compositions

2005302511-Inhibitors of Jun N-terminal kinases for treating glaucomatous retinopathy and ocular diseases